Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $8.93 billion. The enterprise value is $9.29 billion.
| Market Cap | 8.93B |
| Enterprise Value | 9.29B |
Important Dates
The next confirmed earnings date is Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 165.26 million shares outstanding. The number of shares has increased by 4.42% in one year.
| Current Share Class | 165.26M |
| Shares Outstanding | 165.26M |
| Shares Change (YoY) | +4.42% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 105.45% |
| Float | 163.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.22 |
| Forward PS | 9.94 |
| PB Ratio | 20.27 |
| P/TBV Ratio | 20.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.89, with a Debt / Equity ratio of 5.50.
| Current Ratio | 7.89 |
| Quick Ratio | 6.69 |
| Debt / Equity | 5.50 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.15 |
Financial Efficiency
Return on equity (ROE) is -105.51% and return on invested capital (ROIC) is -61.72%.
| Return on Equity (ROE) | -105.51% |
| Return on Assets (ROA) | -12.43% |
| Return on Invested Capital (ROIC) | -61.72% |
| Return on Capital Employed (ROCE) | -3.81% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | $623,189 |
| Profits Per Employee | -$403,272 |
| Employee Count | 1,402 |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IONS has paid $2.79 million in taxes.
| Income Tax | 2.79M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.26% in the last 52 weeks. The beta is 0.37, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +31.26% |
| 50-Day Moving Average | 70.28 |
| 200-Day Moving Average | 75.34 |
| Relative Strength Index (RSI) | 29.24 |
| Average Volume (20 Days) | 4,579,258 |
Short Selling Information
The latest short interest is 20.04 million, so 12.13% of the outstanding shares have been sold short.
| Short Interest | 20.04M |
| Short Previous Month | 17.43M |
| Short % of Shares Out | 12.13% |
| Short % of Float | 12.22% |
| Short Ratio (days to cover) | 5.18 |
Income Statement
In the last 12 months, IONS had revenue of $873.71 million and -$565.39 million in losses. Loss per share was -$3.47.
| Revenue | 873.71M |
| Gross Profit | -66.82M |
| Operating Income | -594.68M |
| Pretax Income | -562.60M |
| Net Income | -565.39M |
| EBITDA | -102.00M |
| EBIT | -102.00M |
| Loss Per Share | -$3.47 |
Balance Sheet
The company has $2.06 billion in cash and $2.42 billion in debt, with a net cash position of -$363.00 million or -$2.20 per share.
| Cash & Cash Equivalents | 2.06B |
| Total Debt | 2.42B |
| Net Cash | -363.00M |
| Net Cash Per Share | -$2.20 |
| Equity (Book Value) | 440.00M |
| Book Value Per Share | 2.67 |
| Working Capital | 2.18B |
Cash Flow
In the last 12 months, operating cash flow was -$910.63 million and capital expenditures -$60.63 million, giving a free cash flow of -$971.26 million.
| Operating Cash Flow | -910.63M |
| Capital Expenditures | -60.63M |
| Depreciation & Amortization | 14.70M |
| Net Borrowing | 502.18M |
| Free Cash Flow | -971.26M |
| FCF Per Share | -$5.88 |
Margins
Gross margin is -7.65%, with operating and profit margins of -68.06% and -64.71%.
| Gross Margin | -7.65% |
| Operating Margin | -68.06% |
| Pretax Margin | -64.39% |
| Profit Margin | -64.71% |
| EBITDA Margin | -11.67% |
| EBIT Margin | -11.67% |
| FCF Margin | n/a |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.42% |
| Shareholder Yield | -4.42% |
| Earnings Yield | -6.33% |
| FCF Yield | -10.88% |
Analyst Forecast
The average price target for IONS is $90.90, which is 68.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $90.90 |
| Price Target Difference | 68.21% |
| Analyst Consensus | Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 28.78% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |